Article: Study shows Genentech's cancer fighter Avastin helps sickest patients.

2004 DEC 21 - (NewsRx.com & NewsRx.net) -- Genentech Inc. said November 29, 2004, its novel colon cancer-fighting drug Avastin helped some of the sickest patients stay alive 2 months longer than expected, giving the drug an additional boost on its way to blockbuster status.

The South San Francisco-based biotechnology titan made the announcement ahead of a major conference for cancer researchers and doctors scheduled for January, when the company said it would release more detailed results from a large-scale human experiment using Avastin in combination with a chemotherapy treatment.

"This study provides additional evidence that adding Avastin to ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!